Viewing Study NCT02019667


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-03-01 @ 9:58 AM
Study NCT ID: NCT02019667
Status: COMPLETED
Last Update Posted: 2020-02-24
First Post: 2013-12-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metabolic Disease View
None Seizures View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GABA View
None Seizures View
None Neurotransmitters View